Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elisa Annie Aquilanti, M.D.

Concepts (83)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telomerase420247451.910 Why?
Glioblastoma5202434830.970 Why?
Brain Neoplasms7202290320.740 Why?
Glioma3202334550.560 Why?
Drug Discovery1202410510.540 Why?
Central Nervous System Neoplasms120249160.520 Why?
Enzyme Inhibitors2202437130.460 Why?
Telomere220249430.290 Why?
Gene Expression Regulation, Neoplastic2201885540.210 Why?
Lomustine12022600.210 Why?
Oligonucleotides120245820.190 Why?
Pathology, Molecular120233280.180 Why?
Cryoelectron Microscopy120246500.180 Why?
Promoter Regions, Genetic3202157900.170 Why?
Drug Design1202410480.160 Why?
Antineoplastic Agents, Alkylating120226170.160 Why?
Chromosomes, Human, Pair 1220186380.150 Why?
DNA Modification Methylases120182100.150 Why?
Neoplasms22024221730.150 Why?
Chromosomes, Human, Pair 19120183500.140 Why?
Tumor Burden1202318920.140 Why?
Mutation72024300530.140 Why?
Immunotherapy2202446520.140 Why?
DNA Repair Enzymes120183460.140 Why?
Lymphoma1202419010.120 Why?
Lung Neoplasms32024133810.100 Why?
Isocitrate Dehydrogenase120189380.100 Why?
Antineoplastic Agents32024136420.100 Why?
Medical Oncology1202323210.100 Why?
Genes, Essential120121850.090 Why?
Gene Deletion1201826650.090 Why?
Tumor Suppressor Proteins2201828050.090 Why?
Combined Modality Therapy1202285270.090 Why?
RNA-Binding Protein FUS12010760.090 Why?
Humans1320247615960.080 Why?
Neoplasm Metastasis1202049150.080 Why?
Prognosis22020296290.080 Why?
Sequence Deletion1201214940.070 Why?
DNA Methylation2201843990.070 Why?
RNA Splicing120109180.060 Why?
Neoplasm Recurrence, Local1202292800.060 Why?
Carcinoma, Non-Small-Cell Lung1202053140.050 Why?
Melanoma1202057090.050 Why?
Molecular Targeted Therapy1201228110.050 Why?
Matrix Metalloproteinase 13120201020.040 Why?
Amyotrophic Lateral Sclerosis1201014690.040 Why?
Genes, myc120203900.040 Why?
Mice, Nude1202036140.030 Why?
Phosphonoacetic Acid12012540.030 Why?
Phosphopyruvate Hydratase120121270.030 Why?
Cell Line22020156010.020 Why?
DNA Copy Number Variations1202020200.020 Why?
Adenovirus E1A Proteins12010740.020 Why?
HEK293 Cells1202042810.020 Why?
Hydroxamic Acids120124810.020 Why?
Polymorphism, Single Nucleotide12009159360.020 Why?
Neoplasm Transplantation1201220160.020 Why?
Cytoplasmic Granules120105740.020 Why?
Genes, Tumor Suppressor1201210620.020 Why?
Gene Knockdown Techniques1201216120.020 Why?
Protein Kinase Inhibitors1202456720.020 Why?
Homozygote1201217760.020 Why?
Nucleic Acid Hybridization1200913020.020 Why?
Loss of Heterozygosity120096620.020 Why?
Green Fluorescent Proteins1201020650.020 Why?
Genomics1202058210.010 Why?
Mice32020815390.010 Why?
DNA, Neoplasm1200917450.010 Why?
RNA, Small Interfering1201234300.010 Why?
Case-Control Studies12020221760.010 Why?
Recombinant Fusion Proteins1201037330.010 Why?
Reverse Transcriptase Polymerase Chain Reaction1200945760.010 Why?
Transcription Factors12020121300.010 Why?
Animals320201684750.010 Why?
Neoplasm Proteins1200936170.010 Why?
Cell Proliferation12012104510.010 Why?
Nerve Tissue Proteins1200944150.010 Why?
Cell Line, Tumor12012169900.010 Why?
DNA-Binding Proteins1201296100.010 Why?
Male120203608460.000 Why?
Female120203927050.000 Why?
Child12009801580.000 Why?
Adult120092212100.000 Why?
Aquilanti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.